Skip to main content
Premium Trial:

Request an Annual Quote

Agilent's Projected Q3 Revenue Decline Improves Original Forecast

NEW YORK (GenomeWeb News) — Agilent Technologies today said it expects third-quarter revenue to decline between 2 percent and 4.8 percent year over year, though it is a 1.5-percent improvement over earlier predictions.
 
During its fiscal second quarter earnings report in May, Agilent had said it expected third-quarter revenue to decline between 3.5 percent and 6.2 percent.  
 
Today, it said it expects revenue for the three months ended June 30 to decline to between $1.38 billion and $1.42 billion from $1.45 billion last year.
 

According to an Agilent spokesperson, last year’s results included revenue from Verigy, the semiconductor business the company spun off during the year. Adjusted for that discontinued operation for the third quarter of 2007, revenue was $1.2 billion, meaning that Agilent’s revised guidance represents a growth of between 11 percent and 15 percent.

 

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.